Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12202-12211

  Khan, Shafqat A ^a   Tyagi, Monica ^a   Sharma, Ajit K ^a   Barreto, Savio G ^b,c   Sirohi, Bhawna ^b   Ramadwar, Mukta ^b   Shrikhande, Shailesh V ^b   Gupta, Sanjay ^a  

^a CANCER RESEARCH INSTITUTE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c Medanta Institute of Digestive and Hepatobiliary Sciences   (India)

Author keywords

Adjacent mucosa; Epithelial cells; Gastric cancer; Immunohistochemistry; Inflammatory cells; Resection margin; Tumor infiltrating immune cells; actin

Indexed keywords

BETA ACTIN; MESSENGER RNA; ACTIN; TUMOR MARKER;

ADULT; ARTICLE; CELL SPECIFICITY; CELLS BY BODY ANATOMY; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIUM CELL; EVALUATION STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING; ADENOCARCINOMA; CANCER GRADING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; UPREGULATION;

ACTINS; ADENOCARCINOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84909606401     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12202     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/ caac.21166]
2. Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32: 3-11 [PMID: 21731209 DOI: 10.4103/0971-5851.81883]
3. Yeole BB. Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. Asian Pac J Cancer Prev 2008; 9: 97-100 [PMID: 18439085]
4. Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 2006; 23 : 192-197 [PMID: 16837811 DOI: 10.1159/000094537]
5. Shrikhande SV, Barreto SG, Talole SD, Vinchurkar K, Annaiah S, Suradkar K, Mehta S, Goel M. D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy. World J Surg Oncol 2013; 11: 31 [PMID: 23375104 DOI: 10.1186/1477-7819-11-31]
6. Rosado JO, Henriques JP, Bonatto D. A systems pharmacology analysis of major chemotherapy combination regimens used in gastric cancer treatment: predicting potential new protein targets and drugs. Curr Cancer Drug Targets 2011; 11: 849-869 [PMID: 21762077]
7. Hofmann WA, de Lanerolle P. Nuclear actin: to polymerize or not to polymerize. J Cell Biol 2006; 172 : 495-496 [PMID: 16476772 DOI: 10.1083/jcb.200601095]
8. Hofmann WA. Cell and molecular biology of nuclear actin. Int Rev Cell Mol Biol 2009; 273: 219-263 [PMID: 19215906 DOI: 10.1016/S1937-6448(08)01806-6]
9. Ruan W, Lai M. Actin, a reliable marker of internal control? Clin Chim Acta 2007; 385: 1-5 [PMID: 17698053 DOI: 10.1016/ j.cca.2007.07.003]
10. Atkins H, Anderson PJ. Actin and tubulin of normal and leukaemic lymphocytes. Biochem J 1982; 207: 535-539 [PMID: 7165706]
11. Lupberger J, Kreuzer KA, Baskaynak G, Peters UR, le Coutre P, Schmidt CA. Quantitative analysis of beta-actin, beta- 2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes 2002; 16: 25-30 [PMID: 12005444 DOI: 10.1006/ mcpr.2001.0392]
12. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, Brittner B, Ludwig B, Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005; 19: 101-109 [PMID: 15680211 DOI: 10.1016/j.mcp.2004.10.001]
13. Leavitt J, Leavitt A, Attallah AM. Dissimilar modes of expression of beta- and gamma-actin in normal and leukemic human T lymphocytes. J Biol Chem 1980; 255 : 4984-4987 [PMID: 6966280]
14. Blomberg J, Andersson M, Fäldt R. Differential pattern of oncogene and beta-actin expression in leukaemic cells from AML patients. Br J Haematol 1987; 65: 83-86 [PMID: 3468999]
15. Nowak D, Skwarek-Maruszewska A, Zemanek-Zboch M, Malicka-Błaszkiewicz M. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. Acta Biochim Pol 2005; 52: 461-468 [PMID: 15940343]
16. Xu J, Zhang Z, Chen J, Liu F, Bai L. Overexpression of β-actin is closely associated with metastasis of gastric cancer. Hepatogastroenterology 2013; 60: 620-623 [PMID: 23635433 DOI: 10.5754/hge11038]
17. Stournaras C, Stiakaki E, Koukouritaki SB, Theodoropoulos PA, Kalmanti M, Fostinis Y, Gravanis A. Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. Biochem Pharmacol 1996; 52: 1339-1346 [PMID: 8937443]
18. Hemstreet GP, Rao J, Hurst RE, Bonner RB, Waliszewski P, Grossman HB, Liebert M, Bane BL. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J Cell Biochem Suppl 1996; 25: 197-204 [PMID: 9027619]
19. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998; 10: 123-130 [PMID: 9484604]
20. Staples CJ, Owens DM, Maier JV, Cato AC, Keyse SM. Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation. J Biol Chem 2010; 285: 25928-25940 [PMID: 20547488 DOI: 10.1074/jbc.M110.117911]
21. Yip WK, Leong VC, Abdullah MA, Yusoff S, Seow HF. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol Rep 2008; 19: 319-328 [PMID: 18202777]
22. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675 [PMID: 22930834]
23. Quitschke WW, Lin ZY, DePonti-Zilli L, Paterson BM. The beta actin promoter. High levels of transcription depend upon a CCAAT binding factor. J Biol Chem 1989; 264: 9539-9546 [PMID: 2722849]
24. Leof EB, Proper JA, Getz MJ, Moses HL. Transforming growth factor type beta regulation of actin mRNA. J Cell Physiol 1986; 127: 83-88 [PMID: 3457016 DOI: 10.1002/jcp.1041270111]
25. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, Kang AH, Moses HL. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem 1988; 263: 3111-3115 [PMID: 3125175]
26. Elder PK, Schmidt LJ, Ono T, Getz MJ. Specific stimulation of actin gene transcription by epidermal growth factor and cycloheximide. Proc Natl Acad Sci USA 1984; 81: 7476-7480 [PMID: 6334309]
27. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009; 77 : 12-21 [PMID: 19439999 DOI: 10.1159/000218166]
28. Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010; 8: 529-538 [PMID: 20353999 DOI: 10.1158/1541-7786.MCR-09-0443]
29. Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptoralpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007; 21: 1132-1147 [PMID: 17312270 DOI: 10.1210/ me.2007-0022]
30. Sikand K, Singh J, Ebron JS, Shukla GC. Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and â-actin are targets of miR-644a. PLoS One 2012; 7: e47510 [PMID: 23091630 DOI: 10.1371/journal.pone.0047510]
31. Popow A, Nowak D, Malicka-Błaszkiewicz M. Actin cytoskeleton and beta-actin expression in correlation with higher invasiveness of selected hepatoma Morris 5123 cells. J Physiol Pharmacol 2006; 57 Suppl 7: 111-123 [PMID: 17228099]
32. Goidin D, Mamessier A, Staquet MJ, Schmitt D, Berthier-Vergnes O. Ribosomal 18S RNA prevails over glyceralde-hyde- 3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem 2001; 295: 17-21 [PMID: 11476540 DOI: 10.1006/abio.2001.5171]
33. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-69 [PMID: 17200707 DOI: 10.1172/JCI30111]
34. Peckham M, Miller G, Wells C, Zicha D, Dunn GA. Specific changes to the mechanism of cell locomotion induced by overexpression of beta-actin. J Cell Sci 2001; 114 : 1367-1377 [PMID: 11257002]
35. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003; 112: 453-465 [PMID: 12600310]
36. Bunnell TM, Burbach BJ, Shimizu Y, Ervasti JM. β-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell 2011; 22: 4047-4058 [PMID: 21900491 DOI: 10.1091/mbc.E11-06-0582]
37. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30: 1073-1081 [PMID: 19468060 DOI: 10.1093/carcin/bgp127]
38. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001; 193: F23-F26 [PMID: 11257144]
39. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12 : 989-995 [PMID: 16467114 DOI: 10.1158/1078-0432.CCR-05-2096]
40. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004; 164 : 689-699 [PMID: 14742272 DOI: 10.1016/S0002-9440(10)63156-2]